Literature DB >> 1337391

Opportunistic intraocular infections in AIDS.

E N Morinelli1, P U Dugel, M Lee, E C Klatt, N A Rao.   

Abstract

In conclusion, this clinicopathologic study has shown that CMV ocular infection is present in about 16% of terminal AIDS patients. The treatment of CMV retinitis reduces the number of CMV-infected nonocular organs and may also lessen the severity and control the spread of concurrent nonocular infection, both of which may prolong survival in AIDS patients. Other opportunistic infections, involving primarily the choroid, were also seen in a number of patients, some of whom had concurrent intraocular infections with CMV and P carinii, M avium-intracellulare, C neoformans. In addition, all of these choroidal infections were components of disseminated infection, underscoring the increasingly important role of the ophthalmologist in the diagnosis and treatment of disseminated opportunistic infections in AIDS.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1337391      PMCID: PMC1298428     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN: 0065-9533


  30 in total

1.  Choroidal lesions in patients with AIDS.

Authors:  M A Rosenblatt; C Cunningham; S Teich; A H Friedman
Journal:  Br J Ophthalmol       Date:  1990-10       Impact factor: 4.638

2.  Bronchoscopy specimens in adults with AIDS. Comparative yields of cytology, histology and culture for diagnosis of infectious agents.

Authors:  C M Weldon-Linne; D P Rhone; R Bourassa
Journal:  Chest       Date:  1990-07       Impact factor: 9.410

3.  Cytomegalovirus retinitis and acquired immunodeficiency syndrome.

Authors:  D A Jabs; C Enger; J G Bartlett
Journal:  Arch Ophthalmol       Date:  1989-01

4.  Survival of patients with the acquired immune deficiency syndrome after development of cytomegalovirus retinopathy. UCLA CMV Retinopathy Study Group.

Authors:  G N Holland; R F Sison; D E Jatulis; M G Haslop; M J Sakamoto; N C Wheeler
Journal:  Ophthalmology       Date:  1990-02       Impact factor: 12.079

5.  The significance of the detection of cytomegalovirus in the bronchoalveolar lavage fluid in AIDS patients with pneumonia.

Authors:  M Bower; S E Barton; M R Nelson; J Bobby; D Smith; M Youle; B G Gazzard
Journal:  AIDS       Date:  1990-04       Impact factor: 4.177

6.  Foscarnet treatment of cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.

Authors:  M A Jacobson; J J O'Donnell; J Mills
Journal:  Antimicrob Agents Chemother       Date:  1989-05       Impact factor: 5.191

7.  Ocular manifestations of acquired immune deficiency syndrome.

Authors:  D A Jabs; W R Green; R Fox; B F Polk; J G Bartlett
Journal:  Ophthalmology       Date:  1989-07       Impact factor: 12.079

8.  A randomized, controlled trial of foscarnet in the treatment of cytomegalovirus retinitis in patients with AIDS.

Authors:  A G Palestine; M A Polis; M D De Smet; B F Baird; J Falloon; J A Kovacs; R T Davey; J J Zurlo; K M Zunich; M Davis
Journal:  Ann Intern Med       Date:  1991-11-01       Impact factor: 25.391

9.  Acquired immune deficiency syndrome. Ocular manifestations.

Authors:  G N Holland; J S Pepose; T H Pettit; M S Gottlieb; R D Yee; R Y Foos
Journal:  Ophthalmology       Date:  1983-08       Impact factor: 12.079

10.  Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device.

Authors:  G E Sanborn; R Anand; R E Torti; S D Nightingale; S X Cal; B Yates; P Ashton; T Smith
Journal:  Arch Ophthalmol       Date:  1992-02
View more
  5 in total

1.  Postmortem histological survey of the ocular lesions in a British population of AIDS patients.

Authors:  I Pecorella; A Ciardi; A Garner; A C McCartney; S Lucas
Journal:  Br J Ophthalmol       Date:  2000-11       Impact factor: 4.638

2.  Utility of tissue culture for detection of Toxoplasma gondii in vitreous humor of patients diagnosed with toxoplasmic retinochoroiditis.

Authors:  D Miller; J Davis; R Rosa; M Diaz; E Perez
Journal:  J Clin Microbiol       Date:  2000-10       Impact factor: 5.948

3.  Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients.

Authors:  A Jayaprakash Patil; Ashish Sharma; M Cristina Kenney; Baruch D Kuppermann
Journal:  Clin Ophthalmol       Date:  2010-03-04

Review 4.  Impact of highly active antiretroviral therapy on organ-specific manifestations of HIV-1 infection.

Authors:  D Torre; F Speranza; R Martegani
Journal:  HIV Med       Date:  2005-03       Impact factor: 3.180

5.  Cytomegalovirus retinitis: the neglected disease of the AIDS pandemic.

Authors:  David Heiden; Nathan Ford; David Wilson; William R Rodriguez; Todd Margolis; Bart Janssens; Martha Bedelu; Nini Tun; Eric Goemaere; Peter Saranchuk; Kalpana Sabapathy; Frank Smithuis; Emmanuel Luyirika; W Lawrence Drew
Journal:  PLoS Med       Date:  2007-12       Impact factor: 11.069

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.